Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:country |
gptkb:Spain
|
| gptkbp:focusesOn |
Early-stage investments
Growth-stage investments |
| gptkbp:foundedIn |
2008
|
| gptkbp:headquartersLocation |
gptkb:Barcelona
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ysios Capital
|
| gptkbp:industry |
gptkb:biotechnology
Life sciences |
| gptkbp:investedIn |
MedLumics
AM-Pharma Aelix Therapeutics Anaconda Biomed AptaTargets Arthex Biotech Inbiomotion Minoryx Therapeutics Oryzon Genomics STAT-Dx Sanifit SparingVision |
| gptkbp:languageOfWork |
gptkb:Spanish
|
| gptkbp:managingPartner |
Joan Perelló
Martí Bonet |
| gptkbp:website |
https://www.ysioscapital.com/
|
| gptkbp:bfsParent |
gptkb:Cristina_Garmendia
|
| gptkbp:bfsLayer |
7
|